health pharma news today obesity drugs glp-1 today WHO Issues First-Ever Guidelines For - Including Popular GLP-1 medications may have
Description
April 15, 2026
Dr Lakshiv Dhingra , Dr Seren Marsh , Abhishek Patel and Dr Victor Chua of Mansfield Advisors consider how the GLP-1 landscape will evolve over the next 10 years in light of: increasing competition and the entry of generics
Given the high demand and the complex and rapidly changing coverage environment, patients, providers, advocates, and policymakers are seeking better information about the insurance coverage landscape
Furthermore, GLP-1R can also become internalized in response to GLP-1 and its analogs, indicating a complex regulatory mechanism that affects gene expression and protein activity [32]
R.JonesN
Wong HJ, Sim B, Teo YH, et al
